Since 1978
"The home of natural thought" NATURAL Immune fraction* and ANTIOXIDANTS,
Some applications of colostrum
Elizabeth
discusses Bobs project
This study though never followed up, could still be beneficial in a number of applications
Bob prepared the medications for this study, think about it, there are many applications for this protocol
PREVENTION OF NEONATAL HERPES VIRUS INFECTION
STATEMENT: The purpose of this study is to develop a protocol that could
prevent newborn infants from contracting Herpes virus hominis
through the birth system by periodic douching of the birth canal
during labor with processed colostrum (PLYMATE) containing
the viral
antibodies
The incidence of progenital Herpes virus hominis (HVH) infection is
increasing at an alarming rate, and many individuals are not aware of having
been infected by the virus. In monitoring a group of 140 pregnant women
without any histories of vaginal lesions suggestive of prior genital infections,
~ we found that nearly 10% of these expectant mothers were shedding the virus
from the cervix at about the 8th month of pregnancy and that 5% of these
shedders continued to do so into the final week of pregnancy. (A significant
rise in indirect hemagglutinating antibody titers correlated with virus
shedding.) Fortunately, all of these women delivered infants without any
eventual neonatal infections. On the other hand, the type II HVH was isolated
from the leukocytes of acutely ill infants averaging 5 days in age and from
tissues of infants, who have died from the infection and were all delivered to
asymptomatic mothers. The attending physicians indicated that these women did
not have any lesions nor showed signs of active infections.
Title
Treatment of multiple sclerosis with anti-measles cow colostrum.
Previous virological and immunological studies have suggested that multiple
sclerosis (MS) is
an auto-immune disease triggered by a virus infection. In order to inhibit the
growth of
measles virus in the patient's jejunum, we obtained an IgA-rich cow colostrum
containing
anti-measles lactoglobulin resistant to proteases. This colostrum was orally
administered to
patients with MS to investigate its effect on the course of the disease.
Measles-positive
antibody colostrum was orally administered every morning to 1 S patients with MS
at a daily
dosage of 100 ml for 30 days. Similarly, measles-negative antibody (less than 8)
control
colostrum was orally administered to S patients. As a clinical assessment,
disability scores
developed by the International Federation of Multiple Sclerosis Societies were
used. As a
result, of 7 hiBh NT titre (S 12-5120) anti-measles colostrum recipients S
patients improved
and 2 remained unchanged... Among 8 low NT titre (8-32) anti-measles colostrum
recipients
5 patients improved and 3 remained unchanged. However, of S negative NT titre
(less than
8) colostrum recipients 2 patients remained unchanged and 3 worsened. No
side-effects
were observed in colostrum recipients. These findings suggest the efficacy of
orally
administered anti-measles colostrum in improving the condition of MS patients (P
less than
0.05).
